维普期刊资源整合服务平台（V6.5）

33篇 您的检索式：作者名="Wittkowsky AK"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy 显示文摘	Higashi MK Veenstra DL Kondo LM Wittkowsky AK Srinouanprachanh SL Farin FM	2002	JAMA2002，287，13：	1
2	Contemporary use of and future roles for heparin in antithrombolic therapy显示文摘	Gibaldi M Wittkowsky AK	1995	J Clin Phapmacol1995，35，11：	1
3	The role of thrombin inhibitionduring percutaneous coronary intervention 显示文摘	Wittkowsky AK	2002	Pharmacotherapy2002，22，62：	1
4	Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions 显示文摘	Wittkowsky AK	2003	Semin Vasc Med2003，3，3：	1
5	Discrepancies in identification of major bleeding events in patients taking warfarin 显示文摘	Seto AC Kenyon K Wittkowsky AK	2008	Pharmaeotherapy2008，28，9：	1
6	Direct thrombim inhibitors for amticoagulatiom 显示文摘	Nutescu EA Wittkowsky AK	2004	Ann Phormacother2004，38，1：	1
7	Association between CYP2C9 genetic variations anticoagulation-related outcomes during warfarin therapy显示文摘	Higashi MK Veenstra DL Kondo LM Wittkowsky AK Srinouanprachanh SL Farin FM	2002	JAMA2002，287，：	1
8	Key articles and guidelines for the prevention of venous thromboembolism显示文摘	Dobesh PP Wittkowsky AK Stacy Z	2009	Pharmacotherapy2009，29，4：	1
9	Effective anticoagulation therapy ; defining the gap between clinical studies and clinical practice 显示文摘	Wittkowsky AK	2004	Am J Manag Care2004，10，10：	1
10	Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy显示文摘	Higashi M Veenstra DL Wittkowsky AK	2002	JAMA2002，287，：	1
11	Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy显示文摘	Higashi MK Veenstra DL Kondo LM Wittkowsky AK Srinouanprachanh SL Farin FM	2002	JAMA2002，287，13：	1
12	Lepirudin dosing in dialysisdependent renal failure显示文摘	Wittkowsky AK Kondo LM	2000	Pharmacotherapy2000，20，：	1
13	Thromboembolic complications of malignancy 显示文摘	Linenberger ML Wittkowsky AK	2005	Oncology2005，19，7：	1
14	Discrepancies in identification of major bleeding events in patients taking warfarin显示文摘	Seto AC Kenyon K Wittkowsky AK	2008	Pharmacotherapy2008，28，9：	1
15	Warfarin- amiodarone drug-drug interactions: determination of (u)/K (I,u) for amiodarone and its plasma metabolites显示文摘	McDonald MG Au NT Wittkowsky AK	2012	Clin Pharmacol Ther2012，91，4：	1
16	Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy显示文摘	Higashi M Veenstra DL Wittkowsky AK	2002	JAMA2002，287，：	1
17	Discrepancies in identification of major bleeding events in patients taking warfarin显示文摘	Seto AC Kenyon K Wittkowsky AK	2008	Pharmacotherapy2008，28，9：	1
18	Novel oral anticoagulants and their role in clinical practice显示文摘	Wittkowsky AK	2011	Pharmacotherapy2011，31，12：	1
19	Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy显示文摘	Higashi MK Veenstra DL Kondo LM Wittkowsky AK Srinouanprachanh SL Farin FM	2002	JAMA2002，287，13：	1
20	Warfarin-amiodarone drug-drug interactions: determination of ( u )/K ( I, u ) for amiodarone and its plasma metabolites 显示文摘	McDonald MG Au NT Wittkowsky AK	2012	Clin Pharmacol Ther2012，91，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示